- Protocol:
|
View/Download (PDF)
- for reference only
|
- Sample Preparation:
| Suggested Procedure |
- Measured Sample Levels:
Measured values represent approximate 'normal' levels in sample, but do not signify the only possible sample levels. Various factors (e.g. sample storage, assay procedure) can affect results. | Human Plasma: 0.88 ng/ml Human Plasma (extracted): 0.13 ng/ml Human Serum: 0.89 ng/ml Human Serum (extracted): 0.05 ng/ml
|
- Sample Extraction:
| Recommended |
- Sensitivity:
Data may differ slightly based on lot. | 0.22 ng/ml |
- Linear Range:
Data may differ slightly based on lot. | 0.22 - 2.28 ng/ml |
- Cross Reactivity:
Peptide |
% |
Orexin A (Human, Bovine, Mouse, Rat) |
100 |
Orexin A (16-33) |
0 |
Orexin B (Human) |
0 |
Agouti-Related Protein (83-132)-Amide (Human) |
0 |
Neuropeptide (Human, Rat) |
0 |
α-MSH |
0 |
Leptin (Human) |
0 |
|
- Intra-assay variation:
| <10% |
- Inter-assay variation:
| <15% |
The orexigenic peptides in children with celiac disease.
Plasma orexin and ghrelin response to the oral glucose tolerance test in obese women.
Brain orexins and wake regulation in rats exposed to maternal deprivation.
Effect of intraperitoneal CCK-8 on food intake and brain orexin-A after 48 h of fasting in the rat.
Cerebrospinal fluid orexin in aneurysmal subarachnoid haemorrhage - a pilot study.
Apelin, orexin-A and leptin plasma levels in morbid obesity and effect of gastric banding.
Social Network Confirmation